A British economist is calling on the world's leading pharmaceutical companies to set up a $2 billion fund to enable research into new antibiotics. A U.K. government-appointed review team into the issue of antibiotic resistance, headed by economist Jim O'Neill, has urged the global pharmaceutical industry to fund a $2 billion innovation fund to kick-start research into new antibiotics.
